subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9

subject_name: magrolimab

object_name: ovarian neoplasm

tested_intervention: unsure


subject: UNII:90YIEHRFJ9

object_name: ovarian carcinoma


subject: UMLS:C3896840

object_name: ovarian cancer


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Unresectable Penile Squamous Cell Carcinoma


subject: UNII:DLE8519RWM

object_name: Penile squamous cell carcinoma metastatic


subject: UNII:DLE8519RWM

object_name: Stage III Penile Cancer AJCC v8


subject: UNII:DLE8519RWM

object_name: Stage IV Penile Cancer AJCC v8


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: rheumatoid arthritis


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: Stomach cancer

tested_intervention: yes


subject: UMLS:C4287707

object_name: gastric cancer


subject: CHEBI:8863

subject_name: Riluzole

object_name: anxiety disorder


subject: CHEBI:8863

object_name: major affective disorder 4


subject: CHEBI:8863

object_name: major affective disorder 7


subject: CHEBI:8863

object_name: major affective disorder 6


subject: CHEBI:8863

object_name: major affective disorder 2


subject: CHEBI:8863

object_name: major affective disorder 8


subject: CHEBI:8863

object_name: major affective disorder 9


subject: CHEBI:8863

object_name: major affective disorder 1


subject: CHEBI:8863

object_name: major affective disorder 5


subject: PUBCHEM.COMPOUND:51059404

subject_name: Blisibimod

object_name: granulomatosis with polyangiitis


subject: PUBCHEM.COMPOUND:51059404

object_name: microscopic polyangiitis


subject: UNII:114VP6C6ES

subject_name: BLISIBIMOD


subject: UNII:114VP6C6ES


subject: UMLS:C3713826


subject: UMLS:C3713826


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Injury of ureter


subject: PUBCHEM.COMPOUND:6096882

object_name: ovarian endometriosis


subject: PUBCHEM.COMPOUND:6096882

object_name: Endometriosis of cul-de-sac


subject: PUBCHEM.COMPOUND:6096882

object_name: endometriosis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C0733521

subject_name: Ara-C

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C0733688


subject: CHEBI:66903

subject_name: Vismodegib

object_name: interstitial lung disease 1


subject: CHEBI:66903

object_name: interstitial lung disease 2


subject: UNII:I60W9520VV

subject_name: Vadadustat

object_name: Hepatic impairment


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: chronic kidney disease


subject: CHEBI:6503

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: UNII:08WG8S0L8D

object_name: clear cell sarcoma


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: episodic ataxia type 2


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: pancreatic neoplasm


subject: UNII:7UQ7X4Y489

object_name: exocrine pancreatic carcinoma


subject: UNII:7UQ7X4Y489

object_name: malignant pancreatic neoplasm


subject: GTOPDB:6803

subject_name: dalteparin

object_name: Thrombosis of blood vessel


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Arrhythmia


subject: UNII:641H0Q518W

object_name: asthma


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Hemodynamic stability


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: gastric neoplasm


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Drug usage


subject: MESH:C000714527

subject_name: Coptis extract

object_name: diverticulitis


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Effects of chemotherapy


subject: UMLS:C4086713

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: UMLS:C4086713

object_name: Recurrence


subject: UMLS:C1873773

subject_name: Ice Pharmaceutical


subject: UMLS:C1873773


subject: UMLS:C1873773


subject: MESH:D007053

subject_name: Ice


subject: MESH:D007053


subject: MESH:D007053


subject: CHEBI:6809

subject_name: Metamfetamine


subject: CHEBI:6809


subject: CHEBI:6809


subject: PR:000005366

subject_name: cocaine esterase


subject: PR:000005366


subject: PR:000005366


subject: PR:000002309


subject: PR:000002309


subject: PR:000002309


subject: CHEBI:16494

subject_name: thioctic acid

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:15365

subject_name: Aspirin

object_name: colon adenoma


subject: UMLS:C1456557

subject_name: Botanical

object_name: otitis media


subject: UMLS:C1456557

object_name: infectious otitis media


subject: UMLS:C1456557

object_name: Otitis Media, CTCAE


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:21628493

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:21628493

object_name: Stroke (heart beat)


subject: PUBCHEM.COMPOUND:21628493

object_name: Stroke, CTCAE


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: CHEBI:8404

subject_name: Prilocaine

object_name: Monoarthritis


subject: CHEBI:8404

object_name: gonarthrosis; primary


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: UNII:7XL5ISS668

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:4305


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: PUBCHEM.COMPOUND:637

subject_name: Cytosine deoxyribonucleoside

object_name: mitochondrial DNA depletion syndrome


subject: PUBCHEM.COMPOUND:637

object_name: mitochondrial encephalomyopathy


subject: PUBCHEM.COMPOUND:637

object_name: Mitochondrial encephalopathy


subject: PUBCHEM.COMPOUND:637

object_name: inborn mitochondrial metabolism disorder


subject: PUBCHEM.COMPOUND:637

object_name: mitochondrial disease


subject: CHEBI:15698

subject_name: Deoxycytidine


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: UMLS:C0086126


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:17748


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: Intracranial Atherosclerosis


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: infant morbidity


subject: CHEBI:139554

object_name: Nutritional anemia


subject: UNII:7XL5ISS668

object_name: T-cell lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Adult Primary Cutaneous Anaplastic Large Cell Lymphoma


subject: CHEBI:63791

object_name: primary cutaneous anaplastic large cell lymphoma


subject: CHEBI:63791


subject: CHEBI:63791

object_name: lymphomatoid papulosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pituitary gland adenoma


subject: CHEBI:41879

object_name: pituitary gland disorder


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: anxiety


subject: HMDB:HMDB0013470

object_name: anxiety disorder


subject: HMDB:HMDB0013470

object_name: Anxiety symptoms


subject: HMDB:HMDB0013470

object_name: Anxiety, CTCAE 3.0


subject: HMDB:HMDB0013470

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: UMLS:C2703133

object_name: leukemia


subject: UMLS:C2703133

object_name: childhood leukemia


subject: UMLS:C2981820

object_name: Hodgkin Disease


subject: UMLS:C2981820

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C2981820

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: CHEBI:145373


subject: UMLS:C5707834

subject_name: Balcinrenone

object_name: chronic kidney disease


subject: UMLS:C5707834

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:80165

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: polymyositis


subject: UNII:I031V2H011

object_name: adult dermatomyositis


subject: UNII:I031V2H011

object_name: dermatomyositis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: carcinoma of esophagus


subject: CHEBI:73604

object_name: esophageal cancer


subject: CHEBI:73604

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:73604

object_name: neoplasm of esophagus


subject: CHEBI:58029

subject_name: cysteaminium

object_name: cystic fibrosis


subject: CHEBI:17141

subject_name: Cysteamine


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Extracorporeal membrane oxygenation complication


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: post-operative atrial fibrillation


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: habitual spontaneous abortion


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin

object_name: iron deficiency anemia


subject: UMLS:C3890596

subject_name: Compound Kushen Injection

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: contrast-induced nephropathy


subject: UMLS:C3852939

object_name: Filoviridae infectious disease


subject: UMLS:C3852939

object_name: Ebola hemorrhagic fever


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: cardiovascular disorder


subject: UMLS:C3529192


subject: UMLS:C3529192

object_name: Chronic kidney disease due to type 2 diabetes mellitus


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: Congenital postural scoliosis


subject: UMLS:C5782829

object_name: scoliosis


subject: UMLS:C5782829

object_name: Scoliosis, CTCAE


subject: UMLS:C5782829

object_name: orthopedic disorders of spine


subject: MESH:C551853

subject_name: Viusid


subject: UMLS:C0730770

subject_name: Lipiodol Ultra fluid

object_name: arteriovenous hemangioma/malformation


subject: UMLS:C0730770

object_name: congenital hemangioma


subject: UMLS:C0730770

object_name: hemangioendothelioma


subject: UMLS:C0730770

object_name: pediatric angiosarcoma


subject: UMLS:C0730770

object_name: angiosarcoma


subject: UMLS:C0730770

object_name: Adult Angiosarcoma


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: uterine fibroid


subject: CHEBI:4806

object_name: vitamin B6 measurement


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:27374

subject_name: Levoinositol


subject: CHEBI:27374


subject: CHEBI:27372


subject: CHEBI:27372


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: osteoarthritis


subject: UMLS:C2986994

object_name: Small cell lung cancer extensive stage


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Cognitive impairment


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:80308

subject_name: substance P

object_name: herpes simplex


subject: CHEBI:80308

object_name: HIV infection


subject: UNII:PY79D6C8RX

subject_name: Crofelemer


subject: UNII:PY79D6C8RX


subject: GTOPDB:13048

subject_name: cerebral dopamine neurotrophic factor

object_name: Parkinson disease


subject: GTOPDB:13048

object_name: brain disorder


subject: GTOPDB:13048

object_name: nervous system disorder


subject: GTOPDB:13048

object_name: neurodegenerative disease


subject: GTOPDB:13048

object_name: movement disorder


subject: PUBCHEM.COMPOUND:122706786

subject_name: vipivotide tetraxetan

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:122706786

object_name: prostate cancer


subject: UMLS:C5238124


subject: UMLS:C5238124


subject: UNII:VE267FC2UB

subject_name: figitumumab

object_name: Childhood Breast Carcinoma


subject: UNII:VE267FC2UB

object_name: breast carcinoma


subject: UNII:VE267FC2UB

object_name: breast cancer


subject: UMLS:C1707143


subject: UMLS:C1707143


subject: UMLS:C1707143


subject: CHEBI:367163

subject_name: Darunavir

object_name: Human Immunodeficiency Virus Positive


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: CHEBI:68606

subject_name: Rilpivirine


subject: UNII:6DXN080KGB

subject_name: FRESPACIGUAT

object_name: pulmonary hypertension, primary, 1


subject: UNII:6DXN080KGB

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:6DXN080KGB

object_name: pulmonary arterial hypertension


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C2348756

object_name: prostate neoplasm


subject: CHEBI:94782

subject_name: Cediranib

object_name: acute myeloid leukemia


subject: UMLS:C1541530


subject: UMLS:C2346567

subject_name: Recentin


subject: CHEBI:8232

subject_name: Piperacillin

object_name: Neonatal Early-Onset Sepsis


subject: UNII:F5UM2KM3W7

subject_name: BENZALKONIUM CHLORIDE

object_name: OPTN-related open angle glaucoma


subject: CHEBI:135611

subject_name: Benzalkonium


subject: PR:000002185

subject_name: Bcl-2 homologous antagonist/killer


subject: CHEBI:3766

subject_name: Clozapine

object_name: treatment-refractory schizophrenia


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: arteriosclerosis disorder


subject: CHEBI:194186

object_name: atherosclerosis


subject: UMLS:C5854475

subject_name: PRMT5 Inhibitor TNG462

object_name: Locally Advanced Malignant Solid Neoplasm


subject: MESH:C000626629

object_name: Solid Neoplasm


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Obstetric Labor Complications


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: insomnia


subject: CHEBI:133017

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:133017

object_name: Insomnia, CTCAE 5.0


subject: MESH:C459360

object_name: Stroke (heart beat)


subject: MESH:C459360

object_name: Stroke, CTCAE


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Very High Risk Prostate Carcinoma


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: interstitial lung disease


subject: CHEBI:72690

object_name: systemic sclerosis


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: CHEBI:8871

subject_name: Risperidone

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic renal carcinoma


subject: CHEBI:72317

object_name: debility; old age


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:233362

object_name: interstitial lung disease specific to childhood


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:133021

subject_name: Venetoclax

object_name: plasma cell leukemia


subject: CHEBI:133021

object_name: amyloidosis


subject: CHEBI:40279

subject_name: Allopurinol

object_name: peripheral vascular disease


subject: CHEBI:40279

object_name: peripheral arterial disease


subject: UNII:BRH40Y9V1Q

subject_name: Lutetium Lu-177

object_name: neuroendocrine neoplasm


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:P93RUU11P7

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C4521107

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: digestive system cancer


subject: CHEBI:9168

subject_name: Sirolimus

object_name: cardiac allograft vasculopathy


subject: CHEBI:72296

subject_name: Apixaban

object_name: membranous glomerulonephritis


subject: CHEBI:35745

object_name: lung cancer


subject: CHEBI:35745

object_name: lung neoplasm


subject: CHEBI:35745

object_name: lung carcinoma


subject: CHEBI:35739

subject_name: Pentetic acid


subject: CHEBI:35739


subject: CHEBI:35739


subject: UNII:XCL1K2T28K

object_name: Recurrent ovarian cancer


subject: UNII:6897GXD6OE

object_name: Transplant-Related Disorder


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Neonatal Late-Onset Sepsis


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: cardiovascular disorder


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Incomplete reversal of neuromuscular block


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:63631

subject_name: Topiramate

object_name: Weight Gain


subject: CHEBI:63631

object_name: Weight Gain, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: pneumonitis


subject: CHEBI:6888

object_name: Pneumonitis, CTCAE


subject: CHEBI:32016

subject_name: Pirfenidone


subject: CHEBI:32016


subject: CHEBI:32016

object_name: cancer


subject: CHEBI:16856

subject_name: Glutathione

object_name: Childhood Breast Carcinoma


subject: CHEBI:16856

object_name: breast carcinoma


subject: CHEBI:16856

object_name: breast cancer


subject: UMLS:C4723695

subject_name: penpulimab

object_name: Advanced cancer


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection

object_name: Stomach cancer


subject: UMLS:C5201230

object_name: gastric cancer


subject: UMLS:C5201230


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: UMLS:C3854151


subject: UMLS:C3854151


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Platinum-Resistant Malignant Female Reproductive System Neoplasm


subject: UNII:28X28X9OKV

object_name: Refractory Malignant Female Reproductive System Neoplasm


subject: UNII:28X28X9OKV

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: UNII:28X28X9OKV

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1709443

subject_name: Rose Bengal Solution PV-10

object_name: skin melanoma


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: pancreatic neoplasm


subject: UNII:11Z5AIU653

object_name: exocrine pancreatic carcinoma


subject: UNII:11Z5AIU653

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C5960313

subject_name: STAT3 Dual Phosphorylation Site Inhibitor YY201

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5960313

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1176324

object_name: thrombocytosis


subject: UMLS:C1176324

object_name: familial thrombocytosis


subject: UMLS:C1176324

object_name: acquired polycythemia vera


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: cognitive/functional effects


subject: PUBCHEM.COMPOUND:43805

object_name: neurotoxicity


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:135901

subject_name: lanreotide

object_name: polycystic liver disease 1


subject: CHEBI:135901

object_name: autosomal dominant polycystic liver disease


subject: CHEBI:135901

object_name: polycystic kidney disease


subject: CHEBI:135901

object_name: liver disorder


subject: CHEBI:135901

object_name: contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A


subject: CHEBI:135901

object_name: Hepatomegaly


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: achondroplasia


subject: UNII:URS0374MIV

subject_name: RIPERTAMAB

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: UMLS:C4053591

subject_name: Ripertamab


subject: CHEBI:63619

subject_name: Propafenone

object_name: atrial fibrillation


subject: CHEBI:63619

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:63619

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Coronavinae infectious disease


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:15365

subject_name: Aspirin

object_name: Blood Pressure Finding


subject: CHEBI:15365

object_name: Systemic arterial pressure


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Diabetes


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3489715

subject_name: indigo naturalis ointment

object_name: atopic eczema


subject: UMLS:C5205033

subject_name: Anti-CD47 Monoclonal Antibody SHR-1603

object_name: adult lymphoma


subject: UMLS:C5205033

object_name: lymphoma


subject: UMLS:C5205033

object_name: pediatric lymphoma


subject: UMLS:C5205033

object_name: Advanced cancer


subject: UMLS:C5205033

object_name: Neoplasms by Histologic Type


subject: UMLS:C5205033

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:3139

subject_name: bleomycin

object_name: Hodgkin's lymphoma, lymphocytic-histiocytic predominance


subject: CHEBI:3139

object_name: Stage II Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Stage I Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Ann Arbor Stage IIB Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Ann Arbor Stage IIA Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Ann Arbor Stage IB Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Ann Arbor Stage IA Hodgkin Lymphoma


subject: CHEBI:3139

object_name: Hodgkin's disease mixed cellularity stage I site unspecified


subject: CHEBI:3139

object_name: Hodgkin's disease nodular sclerosis stage I


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:188072

object_name: Poisoning by, adverse effect of and underdosing of other psychotropic drugs


subject: CHEBI:188072

object_name: mental disorder


subject: CHEBI:188072

object_name: psychiatric disorder


subject: CHEBI:188072

object_name: mood disorder


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Alzheimer disease type 1


subject: CHEBI:47808

object_name: Alzheimer disease


subject: CHEBI:47426

subject_name: Furosemide

object_name: Dialysis hypotension


subject: UNII:3ZO554A4Q8

subject_name: Voxelotor

object_name: Leg Ulcer


subject: UMLS:C5392771

subject_name: Avigan


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: melanoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: trichomoniasis


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: tuberous sclerosis 2


subject: CHEBI:74702

subject_name: Met-Glu

object_name: dengue disease


subject: UNII:M4HNS35MM2

subject_name: ME


subject: PR:000010472

subject_name: macrophage metalloelastase


subject: DRUGBANK:DB05303

object_name: Post-Operative Pain


subject: UMLS:C1832030

object_name: interstitial lung disease 1


subject: UMLS:C1832030

object_name: interstitial lung disease 2


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Emergence Delirium


subject: CHEBI:132922

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:132922

object_name: vitiligo


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C5197986

object_name: Insulin Sensitivity


subject: UMLS:C5197986

object_name: glucose intolerance


subject: CHEBI:233453

object_name: chronic hepatitis C virus infection


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UMLS:C5853508

object_name: Krabbe disease


subject: CHEBI:5163

subject_name: fosinopril

object_name: diabetic kidney disease


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate

object_name: liver neoplasm


subject: CHEBI:73616

subject_name: Met-Val


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: pyoderma gangrenosum


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: Primary dysmenorrhea


subject: CHEBI:18388

subject_name: Apigenin


subject: UMLS:C0939806

subject_name: Matricaria recutita extract


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b


subject: UNII:21K6M2I7AG


subject: UNII:21K6M2I7AG

object_name: pulmonary fibrosis


subject: UNII:21K6M2I7AG

object_name: Pulmonary Fibrosis, CTCAE


subject: UNII:21K6M2I7AG

object_name: lung disorder


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: CHEBI:4911

subject_name: Etoposide

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5787192

subject_name: LAM 561

object_name: High grade glioma


subject: UMLS:C5787192

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:95165

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:95165

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:95165

object_name: B-cell lymphoma refractory


subject: CHEBI:95165

object_name: B-cell lymphoma recurrent


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:39IS23Q1EW

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:39IS23Q1EW

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:39IS23Q1EW


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C1136177

subject_name: Sirtuins

object_name: liver carcinoma


subject: UMLS:C5555083

subject_name: Microbiota-based Formulation RBX7455

object_name: Clostridium difficile colitis


subject: UMLS:C5555083

object_name: clostridium difficile infection


subject: UMLS:C4733572

subject_name: Synthetic Plumbagin PCUR-101

object_name: prostate carcinoma


subject: UMLS:C4733572

object_name: prostate cancer


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: non-small cell lung carcinoma


subject: UMLS:C0082559

subject_name: Feiba

object_name: hemophilia A


subject: UMLS:C3641720

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C2981617

subject_name: Clevidipine Butyrate Injectable Emulsion

object_name: malignant hypertension


subject: UMLS:C2981617

object_name: Hypertensive emergency


subject: UMLS:C2981617

object_name: Hypertensive crisis


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: osteogenesis imperfecta


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: transient ischemic attack


subject: CHEBI:3561

subject_name: Cetirizine

object_name: neuromyelitis optica


subject: UMLS:C2826158

subject_name: Selectikine

object_name: lung cancer


subject: UMLS:C2826158

object_name: lung neoplasm


subject: UMLS:C2826158

object_name: lung carcinoma


subject: UMLS:C2826158


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: autoimmune hemolytic anemia, warm type


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE

object_name: Cutaneous neurofibroma


subject: UNII:807ME4B7IJ

object_name: neurofibromatosis 1


subject: UNII:807ME4B7IJ

object_name: neurofibromatosis type 1


subject: UNII:807ME4B7IJ

object_name: optic nerve glioma


subject: CHEBI:90227

subject_name: Selumetinib


subject: DRUGBANK:DB10629

subject_name: Blueberry

object_name: muscle injury


subject: MESH:C000721609

subject_name: blueberry extract


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: intracranial thrombosis


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: UNII:WGD229O42W

subject_name: Tenecteplase


subject: CHEBI:49575

subject_name: Diazepam

object_name: rheumatoid arthritis


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Seizure Related to COVID-19


subject: CHEBI:28939

object_name: epilepsy


subject: CHEBI:28939

object_name: visual epilepsy


subject: CHEBI:28939

object_name: Irritability


subject: CHEBI:28939

object_name: Irritability, CTCAE


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: UMLS:C1530677

object_name: Unresectable Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:135566117

subject_name: Aliqopa

object_name: diffuse large B-cell lymphoma


subject: UNII:H3598Y1TLJ

subject_name: VITESPEN

object_name: malignant soft tissue neoplasm


subject: UNII:H3598Y1TLJ

object_name: sarcoma


subject: UMLS:C0935952

subject_name: Oncophage


subject: UMLS:C0935952


subject: UMLS:C5706406

subject_name: PD-L1 Inhibitor BPI-371153

object_name: adult lymphoma


subject: UMLS:C5706406

object_name: lymphoma


subject: UMLS:C5706406

object_name: pediatric lymphoma


subject: UMLS:C5706406

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706406

object_name: liver carcinoma


subject: UMLS:C5706406

object_name: Klatskin Tumor


subject: UMLS:C5706406

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297771

object_name: granulomatosis with polyangiitis


subject: CHEMBL.COMPOUND:CHEMBL4297771

object_name: vasculitis


subject: CHEMBL.COMPOUND:CHEMBL4297771

object_name: Vasculitis, CTCAE


subject: CHEBI:30145

subject_name: lithium atom

object_name: Mental deterioration


subject: CHEBI:30145

object_name: brain neoplasm


subject: CHEBI:30145

object_name: amnesia


subject: CHEBI:30145

object_name: Memory Impairment, CTCAE 5.0


subject: CHEBI:30145

object_name: Adverse effect of radiation therapy


subject: CHEBI:30145

object_name: Disorder due to radiotherapy


subject: CHEBI:30145

object_name: Late effect of radiation


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C4684972

subject_name: Microtubule Inhibitor SCB01A

object_name: head and neck neoplasm


subject: UMLS:C5222440

subject_name: Fondaparinux Sodium Injection

object_name: kidney failure


subject: UNII:W4S5EBH81C

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB05970


subject: UMLS:C4683552

object_name: lung cancer


subject: UMLS:C4683552

object_name: lung neoplasm


subject: UMLS:C4683552

object_name: lung carcinoma


subject: UMLS:C4683552

object_name: non-small cell lung carcinoma


subject: UMLS:C2983764

object_name: glioblastoma


subject: UMLS:C2983764

object_name: Brain Stem Glioblastoma


subject: UMLS:C2983764

object_name: glioma susceptibility 1


subject: UMLS:C2983764

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2983764

object_name: clear cell renal carcinoma


subject: UMLS:C2983764

object_name: renal cell adenocarcinoma


subject: UMLS:C2983764

object_name: renal cell carcinoma


subject: UMLS:C2983764

object_name: colorectal cancer


subject: UMLS:C2983764

object_name: colorectal carcinoma


subject: UMLS:C2983764

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2983764

object_name: Adult Gliosarcoma


subject: UMLS:C2983764

object_name: gliosarcoma


subject: UMLS:C2983764

object_name: Childhood Gliosarcoma


subject: CHEBI:231693

subject_name: Capmatinib


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:231693


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: UNII:2S9ZZM9Q9V

object_name: cholangiocarcinoma of the gallbladder


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Cancer of Gallbladder


subject: UNII:2S9ZZM9Q9V

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: GTOPDB:12517

subject_name: tafolecimab

object_name: acute myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL4594554

subject_name: TAFOLECIMAB


subject: UMLS:C5419329

subject_name: Tafolecimab


subject: CHEBI:6801

subject_name: Metformin

object_name: Huntington disease


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: urgency urinary incontinence


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: aneurysm


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: fetal growth restriction


subject: PUBCHEM.COMPOUND:126456119

object_name: Fetal Growth Retardation, CTCAE


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UMLS:C4763502

subject_name: Surzebiclimab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4763502

object_name: Neck Carcinoma


subject: UMLS:C4763502

object_name: head and neck neoplasm


subject: UMLS:C4763502

object_name: head and neck cancer


subject: UMLS:C5555561

subject_name: Anti-LAG-3 Monoclonal Antibody LBL-007


subject: UMLS:C5555561


subject: UMLS:C5555561


subject: UMLS:C5555561


subject: MESH:D056692

subject_name: Prebiotics

object_name: mood (physical finding)


subject: CHEBI:47554

subject_name: Ethyl chloride

object_name: Surgical procedure finding


subject: CHEBI:10093

subject_name: Yohimbine

object_name: borderline personality disorder


subject: CHEBI:77733

subject_name: Verapamil

object_name: Crohn disease


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant

object_name: acute myeloid leukemia


subject: UMLS:C1522569

object_name: Myelodysplasia


subject: UMLS:C1522569

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1522569

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1522569

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Postmenopausal


subject: PUBCHEM.COMPOUND:21628493

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:21628493

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:21628493

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:21628493

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: CHEBI:3996

subject_name: Cyclobenzaprine

object_name: fibromyalgia


subject: CHEBI:3996

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:3996

object_name: Fatigue


subject: CHEBI:135193

subject_name: Fospropofol

object_name: Ineffective airway clearance


subject: UNII:JNG8L9460Y

subject_name: Ulodesine

object_name: gout


subject: UNII:JNG8L9460Y

object_name: Hyperuricemia


subject: UNII:JNG8L9460Y

object_name: Hyperuricemia, CTCAE


subject: UNII:JNG8L9460Y

object_name: arthropathy


subject: UNII:JNG8L9460Y

object_name: Abnormal joint morphology


subject: UNII:JNG8L9460Y

object_name: arthritis


subject: UNII:JNG8L9460Y

object_name: Arthritis, CTCAE


subject: CHEBI:521033

subject_name: Dutasteride

object_name: lower urinary tract symptom


subject: CHEBI:521033

object_name: impotence


subject: CHEBI:521033

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:521033

object_name: Erectile dysfunction


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: prostate carcinoma


subject: CHEBI:41774

object_name: prostate cancer


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:185135

subject_name: Polyvidone

object_name: prostate disorder


subject: CHEBI:185135

object_name: misadventure during aspirating needle biopsy


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:10033

subject_name: Warfarin

object_name: Liver Fibrosis


subject: UMLS:C3537195

subject_name: Cannabis-Based Oromucosal Spray GW-1000-02

object_name: Spasticity, CTCAE


subject: UMLS:C3537195

object_name: Spasticity


subject: CHEBI:5383

subject_name: Glimepiride

object_name: Insulin resistance


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:M170940PMI

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:M170940PMI

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:M170940PMI

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:M170940PMI

object_name: fallopian tube endometrioid adenocarcinoma


subject: UNII:M170940PMI

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:M170940PMI

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:M170940PMI

object_name: high grade ovarian serous adenocarcinoma


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C5417877

object_name: asthma


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Low back pain


subject: CHEBI:2677

subject_name: Augmentin

object_name: jaw fracture


subject: RXCUI:151392


subject: PUBCHEM.COMPOUND:6419884

subject_name: Cleocin

object_name: Infection


subject: PUBCHEM.COMPOUND:6419884

object_name: infectious disease


subject: PUBCHEM.COMPOUND:6419884

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:6419884


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3745


subject: CHEBI:3745


subject: RXCUI:57773

subject_name: Unasyn


subject: RXCUI:57773


subject: RXCUI:57773


subject: RXCUI:57773


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: malignant glioma


subject: CHEBI:15698

object_name: Childhood Astrocytoma


subject: CHEBI:15698

object_name: glioma susceptibility 1


subject: CHEBI:15698

object_name: astrocytic tumor


subject: CHEBI:15698

object_name: astrocytoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:25805

subject_name: oxygen atom

object_name: pulmonary fibrosis


subject: CHEBI:25805

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:44915

subject_name: Propofol

object_name: Failed or difficult intubation


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:8884

subject_name: Rocuronium


subject: UMLS:C0003241

subject_name: Antibodies

object_name: colorectal cancer


subject: UMLS:C0003241

object_name: colorectal carcinoma


subject: UMLS:C0003241

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0003241

object_name: colorectal neoplasm


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: UMLS:C0021027


subject: UMLS:C0021027


subject: UMLS:C0021027


subject: CHEBI:5441

subject_name: Glyburide

object_name: Premature birth


subject: CHEBI:5441

object_name: Transitory neonatal hypoglycemia


subject: CHEBI:5441

object_name: Glibenclamide adverse reaction


subject: CHEBI:6931

subject_name: Midazolam

object_name: Acute Pain


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: anxiety


subject: CHEBI:76128

object_name: anxiety disorder


subject: CHEBI:76128

object_name: Anxiety symptoms


subject: CHEBI:76128

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:76128

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C1512474

subject_name: Histone deacetylase inhibitor

object_name: melanoma


subject: UMLS:C3537120

subject_name: Histone Deacetylase Inhibitor [EPC]


subject: UMLS:C5966136


subject: CHEBI:176724

subject_name: Etiracetam

object_name: motor neuron disorder


subject: CHEBI:176724

object_name: progressive muscular atrophy


subject: CHEBI:176724

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:176724

object_name: amyotrophic lateral sclerosis


subject: CHEBI:176724

object_name: lateral sclerosis


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: UMLS:C3641186

subject_name: PEG-based Laxative NER1006

object_name: colonic disease


subject: UNII:0WA1B15A1Z

subject_name: Polaprezinc

object_name: microinvasive gastric cancer


subject: UNII:0WA1B15A1Z

object_name: gastric adenoma


subject: CHEBI:15727

subject_name: Carnosine


subject: CHEBI:15727


subject: UMLS:C0078737


subject: UMLS:C0078737


subject: CHEBI:32090

subject_name: Rebamipide


subject: CHEBI:32090


subject: UNII:K9WR6LRA5D

object_name: interstitial lung disease 1


subject: UNII:K9WR6LRA5D

object_name: interstitial lung disease 2


subject: CHEBI:93109

subject_name: Semaxanib

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:93109

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:93109

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:93109

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:93109

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:93109

object_name: Rectal cancer stage IV


subject: CHEBI:93109

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:93109

object_name: Recurrent Rectal Cancer


subject: CHEBI:93109

object_name: colon adenocarcinoma


subject: CHEBI:93109

object_name: rectum adenocarcinoma


subject: CHEBI:93109

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:93109

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:93109

object_name: Stage III Colon Cancer


subject: CHEBI:93109

object_name: Colon cancer recurrent


subject: CHEBI:93109

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:93109

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:93109

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:93109

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:91083

subject_name: Romiplostim

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:91083

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:91083

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:91083

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:91083

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:91083

object_name: Rectal cancer stage IV


subject: CHEBI:91083

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:91083

object_name: Recurrent Rectal Cancer


subject: CHEBI:91083

object_name: colon adenocarcinoma


subject: CHEBI:91083

object_name: rectum adenocarcinoma


subject: CHEBI:91083

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:91083

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:91083

object_name: Stage III Colon Cancer


subject: CHEBI:91083

object_name: Colon cancer recurrent


subject: CHEBI:91083

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:91083

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:91083

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:91083

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C3887574

object_name: Small cell lung cancer extensive stage


subject: CHEBI:38721

subject_name: Methamidophos

object_name: pancreatic adenocarcinoma


subject: UMLS:C4330723

subject_name: Multiple TAA-loaded Dendritic Cell Vaccine

object_name: malignant soft tissue neoplasm


subject: UMLS:C4330723

object_name: sarcoma


subject: UNII:DW94IAT0LS

object_name: metastatic melanoma


subject: UNII:DW94IAT0LS

object_name: Melanoma and other malignant neoplasms of skin (C43-C44)


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: liver cancer


subject: PUBCHEM.COMPOUND:368860

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:368860

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:368860

object_name: extrahepatic bile duct carcinoma


subject: PUBCHEM.COMPOUND:368860

object_name: malignant tumor of extrahepatic bile duct


subject: PUBCHEM.COMPOUND:368860

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:368860

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Stage III Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: gallbladder carcinoma


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: age-related macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:MW2AIJ8USP

subject_name: Elubrixin

object_name: cystic fibrosis


subject: UNII:5970HH9923

subject_name: Mafosfamide

object_name: adult lymphoma


subject: UNII:5970HH9923

object_name: lymphoma


subject: UNII:5970HH9923

object_name: pediatric lymphoma


subject: UNII:5970HH9923

object_name: leukemia


subject: UNII:5970HH9923

object_name: childhood leukemia


subject: UNII:5970HH9923

object_name: tumor of meninges


subject: UNII:5970HH9923

object_name: meningioma


subject: CHEBI:30145

subject_name: lithium atom

object_name: colorectal neoplasm


subject: CHEBI:30145

object_name: neoplasm of esophagus


subject: CHEBI:30145

object_name: gastric neoplasm


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: CHEBI:17460

subject_name: Thioctamide

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:146273261

object_name: Sicca Syndrome


subject: PUBCHEM.COMPOUND:146273261

object_name: Primary Sjögren's syndrome


subject: PUBCHEM.COMPOUND:6335487

object_name: subarachnoid hemorrhage


subject: PUBCHEM.COMPOUND:6335487

object_name: Sodium disorder


subject: PUBCHEM.COMPOUND:6335487

object_name: Critical Illness


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:9434

object_name: kidney failure


subject: UMLS:C0591716

subject_name: Lederfolin

object_name: colon carcinoma


subject: UMLS:C0591716

object_name: colorectal cancer


subject: UMLS:C0591716

object_name: colon cancer


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:231601

object_name: rectal cancer


subject: CHEBI:231601

object_name: Childhood Rectal Carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH

object_name: rectum adenocarcinoma


subject: UNII:234248D0HH

object_name: rectal carcinoma


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Thumb osteoarthritis


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:52010

subject_name: chlorphenamine

object_name: Atopic rhinitis


subject: CHEBI:46295

subject_name: Vardenafil

object_name: Reperfusion Injury


subject: UMLS:C1328728

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5963501

subject_name: Copper Cu 64 LNTH-1363S

object_name: malignant soft tissue neoplasm


subject: UMLS:C5963501

object_name: sarcoma


subject: UMLS:C5963501

object_name: Stomach cancer


subject: UMLS:C5963501

object_name: gastric cancer


subject: UMLS:C5963501

object_name: Metastatic sarcoma


subject: UMLS:C5963501

object_name: pancreatic neoplasm


subject: UMLS:C5963501

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5963501

object_name: malignant pancreatic neoplasm


subject: UMLS:C5963501

object_name: carcinoma of esophagus


subject: UMLS:C5963501

object_name: esophageal cancer


subject: UMLS:C5963501

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5963501

object_name: neoplasm of esophagus


subject: UMLS:C5963501

object_name: colorectal cancer


subject: UMLS:C5963501

object_name: colorectal carcinoma


subject: UMLS:C5963501

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: schizophrenia


subject: CHEBI:28787

object_name: psychosis


subject: CHEBI:24848

subject_name: inositol

object_name: Prediabetes


subject: CHEBI:24848

object_name: Dyslipidemia


subject: UNII:6R5034F862

object_name: interstitial cystitis


subject: UNII:6R5034F862

object_name: Painful Bladder Syndrome


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: cardiovascular disorder


subject: CHEBI:3311

object_name: type 2 diabetes mellitus


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: kwashiorkor


subject: CHEBI:51254

object_name: marasmus


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:3485

subject_name: Cefdinir


subject: CHEBI:3485


subject: UMLS:C4725787

subject_name: SMAC Mimetic BI 891065

object_name: childhood neoplasm


subject: UMLS:C4725787

object_name: neoplastic syndrome


subject: UMLS:C4725787

object_name: cancer or benign tumor


subject: UNII:P5DKZ70636

subject_name: Paxalisib

object_name: Childhood Breast Carcinoma


subject: UNII:P5DKZ70636

object_name: breast carcinoma


subject: UNII:P5DKZ70636

object_name: breast cancer


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Malignant neoplasm of pancreas resectable


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:140621

subject_name: Cisatracurium


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:9939

subject_name: Vecuronium


subject: PUBCHEM.COMPOUND:86583336

subject_name: Evotaz

object_name: HIV infection


subject: RXCUI:1601650

subject_name: atazanavir / cobicistat Oral Product


subject: UMLS:C4547518

object_name: sickle cell disease


subject: CHEBI:38899

subject_name: Tetrafluoroborate

object_name: endometrial cancer


subject: CHEBI:38899

object_name: uterine corpus cancer


subject: CHEBI:38899

object_name: endometrial carcinoma


subject: CHEBI:38899

object_name: plasma cell myeloma


subject: CHEBI:94366

subject_name: itraconazole

object_name: cardiovascular disorder


subject: CHEBI:94366

object_name: heart failure


subject: CHEBI:94366

object_name: Heart Failure, CTCAE


subject: MESH:C007765

subject_name: formatrix

object_name: Turner syndrome


subject: CHEBI:50113

subject_name: androgen


subject: UMLS:C3536949

subject_name: Androgen [EPC]


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: ovarian carcinosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: uterine carcinosarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:131167

subject_name: Losmapimod

object_name: COPD, severe early onset


subject: CHEBI:131167

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3272847


subject: UMLS:C3272847


subject: UMLS:C1522537

subject_name: Recombinant Interferon

object_name: multiple sclerosis


subject: UMLS:C0021747

subject_name: Interferons


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Chronic uremia


subject: UMLS:C2985193

subject_name: Monofer


subject: CHEBI:177451

subject_name: Fasiglifam

object_name: chronic kidney disease


subject: CHEBI:177451

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:6504

object_name: bipolar II disorder


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: adrenoleukodystrophy


subject: CHEBI:47612

object_name: adrenomyeloneuropathy


subject: CHEBI:47612

object_name: X-linked cerebral adrenoleukodystrophy


subject: UMLS:C3274562

subject_name: Beta-lapachone Prodrug ARQ 761

object_name: Solid Neoplasm


subject: CHEBI:6456

subject_name: Lidocaine

object_name: oropharyngeal carcinoma


subject: CHEBI:6456

object_name: oropharynx cancer


subject: CHEBI:6456

object_name: squamous cell carcinoma


subject: CHEBI:6456

object_name: Human Papilloma Virus, Female


subject: CHEBI:6456

object_name: Human Papilloma Virus, Male


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: follicular lymphoma


subject: UNII:06P3KLK2J8

object_name: marginal zone lymphoma


subject: UNII:06P3KLK2J8

object_name: MALT lymphoma


subject: UNII:06P3KLK2J8

object_name: Indolent Non-Hodgkin Lymphoma


subject: UNII:06P3KLK2J8

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: UMLS:C4725069


subject: UMLS:C4725069


subject: UMLS:C4725069


subject: CHEBI:4672

subject_name: Docetaxel

object_name: biliary tract neoplasm


subject: CHEBI:9316

subject_name: Sufentanil

object_name: aortic aneurysm


subject: CHEBI:9316

object_name: Aortic aneurysm without mention of rupture NOS


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:43805

object_name: liver disorder


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UNII:TA3QN7788D

object_name: acute myeloid leukemia by FAB classification


subject: UNII:TA3QN7788D

object_name: acute myeloid leukemia


subject: UNII:TA3QN7788D

object_name: Myelodysplasia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Did not receive therapy or drug for


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:50858

subject_name: corticosteroid

object_name: ulcerative colitis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Fanconi anemia


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: small intestine cancer


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: small intestine carcinoma


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: colon carcinoma


subject: CHEBI:4806

object_name: colorectal cancer


subject: CHEBI:4806

object_name: colon cancer


subject: DRUGBANK:DB16543

subject_name: Lactobacillus gasseri

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB16543

object_name: obesity


subject: DRUGBANK:DB16543

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:53462729

subject_name: Hebevinoside I


subject: PUBCHEM.COMPOUND:53462729


subject: PUBCHEM.COMPOUND:53462729


subject: UMLS:C5241521

subject_name: Lac vaccinum


subject: UMLS:C5241521


subject: UMLS:C5241521


subject: CHEBI:90184

subject_name: LAC dye


subject: CHEBI:90184


subject: CHEBI:90184


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: UNII:U946SH95EE

subject_name: Milk thistle


subject: UNII:U946SH95EE


subject: UNII:U946SH95EE


subject: UMLS:C0872906

subject_name: milk thistle seed extract


subject: UMLS:C0872906


subject: UMLS:C0872906


subject: CHEBI:73614

subject_name: Met-Thr


subject: CHEBI:73614


subject: CHEBI:73614


subject: CHEBI:33361

subject_name: meitnerium atom


subject: CHEBI:33361


subject: CHEBI:33361


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: PR:000010231


subject: CHEBI:36219

subject_name: lactose


subject: CHEBI:36219


subject: CHEBI:36219


subject: CHEBI:44445

subject_name: Nimesulide

object_name: Acute and chronic inflammation


subject: CHEBI:44445

object_name: dyspepsia


subject: CHEBI:44445

object_name: Dyspepsia, CTCAE


subject: CHEBI:7915

subject_name: Pantoprazole


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: neoplasm


subject: UMLS:C0013227

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0013227

object_name: Embolism, Tumor


subject: UMLS:C0013227

object_name: Neoplasm Metastasis


subject: UMLS:C0013227

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C0013227

object_name: Stomach cancer


subject: UMLS:C0013227

object_name: gastric cancer


subject: UMLS:C0013227

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C0013227

object_name: bladder tumor


subject: UMLS:C0013227

object_name: urinary bladder carcinoma


subject: UMLS:C0013227

object_name: urinary bladder cancer


subject: UMLS:C0013227

object_name: childhood bladder carcinoma


subject: UMLS:C0013227

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0013227

object_name: liver carcinoma


subject: UMLS:C0013227

object_name: urothelial carcinoma


subject: UMLS:C0013227

object_name: transitional cell carcinoma


subject: UMLS:C0013227

object_name: urothelial neoplasm


subject: UMLS:C0013227

object_name: trabecular adenocarcinoma


subject: UMLS:C0013227

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C0013227

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0013227

object_name: renal cell adenocarcinoma


subject: UMLS:C0013227

object_name: renal cell carcinoma


subject: UMLS:C0013227

object_name: malignant soft tissue neoplasm


subject: UMLS:C0013227

object_name: sarcoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance

object_name: neoplasm


subject: UMLS:C1254351

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1254351

object_name: Embolism, Tumor


subject: UMLS:C1254351

object_name: Neoplasm Metastasis


subject: UMLS:C1254351

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C1254351

object_name: Stomach cancer


subject: UMLS:C1254351

object_name: gastric cancer


subject: UMLS:C1254351

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C1254351

object_name: bladder tumor


subject: UMLS:C1254351

object_name: urinary bladder carcinoma


subject: UMLS:C1254351

object_name: urinary bladder cancer


subject: UMLS:C1254351

object_name: childhood bladder carcinoma


subject: UMLS:C1254351

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1254351

object_name: liver carcinoma


subject: UMLS:C1254351

object_name: urothelial carcinoma


subject: UMLS:C1254351

object_name: transitional cell carcinoma


subject: UMLS:C1254351

object_name: urothelial neoplasm


subject: UMLS:C1254351

object_name: trabecular adenocarcinoma


subject: UMLS:C1254351

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C1254351

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1254351

object_name: renal cell adenocarcinoma


subject: UMLS:C1254351

object_name: renal cell carcinoma


subject: UMLS:C1254351

object_name: malignant soft tissue neoplasm


subject: UMLS:C1254351

object_name: sarcoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:KXG2PJ551I

object_name: Locally Advanced Malignant Neoplasm


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C0908244

subject_name: NXY 059

object_name: transient ischemic attack


subject: UMLS:C0908244

object_name: stroke disorder


subject: CHEBI:50858

subject_name: corticosteroid

object_name: bursitis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]

object_name: frozen shoulder


subject: UMLS:C3536709


subject: UNII:D07V79Q44T

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1566164


subject: CHEBI:6942

subject_name: Minoxidil

object_name: Alopecia, CTCAE


subject: CHEBI:23965

subject_name: estradiol

object_name: ulcer; vagina, pessary


subject: CHEBI:23965

object_name: Urinary incontinence


subject: CHEBI:23965

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:23965

object_name: pelvic organ prolapse


subject: CHEBI:38940

subject_name: Sunitinib

object_name: testicular germ cell tumor 1


subject: CHEBI:38940

object_name: testicular germ cell tumor


subject: CHEBI:38940

object_name: childhood testicular germ cell tumor


subject: CHEBI:38940

object_name: extragonadal germ cell tumor


subject: CHEBI:38940

object_name: Childhood Teratoma


subject: CHEBI:38940

object_name: adult teratoma


subject: CHEBI:38940

object_name: teratoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:231614

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:231614

object_name: Castration Levels of Testosterone


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2344255

subject_name: BD Alcohol

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:52683

subject_name: Butylene glycol


subject: UMLS:C4724025

subject_name: babaodan capsule


subject: UMLS:C5551437

subject_name: babao dan


subject: CHEBI:27732

subject_name: Caffeine

object_name: respiratory system disorder


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Chronic lymphoid leukemia in remission


subject: CHEBI:71219

subject_name: Pazopanib

object_name: solitary fibrous tumor


subject: CHEBI:71219

object_name: adult myxoid chondrosarcoma


subject: CHEBI:71219

object_name: extraskeletal myxoid chondrosarcoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Muscle Atrophy


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: Stress urinary incontinence


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UMLS:C5666890

subject_name: BTK Degrader BGB-16673

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:135718449

object_name: muscular dystrophy


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline

object_name: heart failure


subject: PUBCHEM.COMPOUND:148193

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:148193

object_name: kidney failure


subject: UNII:41XGO0VS1U

object_name: carcinoma of biliary tract


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C2342851

subject_name: DIGESTIVE AID

object_name: DYSPEPSIA CHRONIC


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1250042

object_name: obesity


subject: UMLS:C1250042

object_name: Obesity, CTCAE


subject: CHEBI:567361

subject_name: Cladribine

object_name: Multiple sclerosis relapse


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: ovarian sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: adult epithelioid sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Angiosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: stage III adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Leiomyosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: leiomyosarcoma of the corpus uteri


subject: PUBCHEM.COMPOUND:131769963

object_name: adult malignant schwannoma


subject: PUBCHEM.COMPOUND:131769963

object_name: undifferentiated pleomorphic sarcoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:145371

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:145371

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEBI:145371

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75045

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:9654

subject_name: Trazodone

object_name: end stage renal failure


subject: CHEBI:9654

object_name: Chronic uremia


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: carcinoma


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z

object_name: Neck Carcinoma


subject: UNII:6XG22YQM2Z

object_name: head and neck neoplasm


subject: UNII:6XG22YQM2Z

object_name: head and neck cancer


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011

object_name: squamous cell carcinoma


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011

object_name: cancer


subject: UNII:I031V2H011

object_name: neoplasm


subject: PR:000006926

subject_name: embryonal Fyn-associated substrate

object_name: Unresectable Hepatocellular Carcinoma


subject: PR:000013004

subject_name: DNA-directed RNA polymerase III subunit RPC5


subject: CHEBI:25357

subject_name: mitomycin

object_name: gastric adenocarcinoma


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: UMLS:C3827149

object_name: Microsatellite instability-high colorectal cancer


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Multiple disability


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Renal cancer metastatic


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: premature ejaculation


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Primary gout


subject: CHEBI:90620

subject_name: Vatalanib

object_name: malignant soft tissue neoplasm


subject: CHEBI:90620

object_name: sarcoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: Cough


subject: CHEBI:5551

object_name: Cough, CTCAE


subject: UNII:I139E44NHL

subject_name: Potassium iodate


subject: UNII:I139E44NHL


subject: CHEBI:32599

object_name: osteoarthritis, knee


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage III Nasopharyngeal Carcinoma


subject: CHEBI:175901

object_name: Stage II Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:175901

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:175901

object_name: EBV Infection


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Presenile dementia


subject: CHEBI:17925

object_name: dementia


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:18394

subject_name: Palatinose


subject: CHEBI:18394


subject: UNII:V59P50X4UY

subject_name: isomaltulose


subject: UNII:V59P50X4UY


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


subject: UMLS:C1161331


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:4026

object_name: Recurrent Childhood Brain Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Refractory Brain Neoplasm


subject: CHEBI:70839

object_name: Recurrent Brain Neoplasm


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:79699

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18

object_name: head and neck squamous cell carcinoma


subject: CHEBI:32071

subject_name: Prulifloxacin

object_name: urinary tract infection


subject: CHEBI:32071

object_name: bacterial urinary tract infection


subject: CHEBI:32071

object_name: Urinary Tract Infection, CTCAE


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: colorectal cancer


subject: UMLS:C0360094

object_name: colorectal carcinoma


subject: UMLS:C0360094

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0360094

object_name: Inflammation


subject: UMLS:C0360094

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0360094

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:148293990

object_name: atopic eczema


subject: DRUGBANK:DB19143


subject: CHEBI:64312

subject_name: Memantine

object_name: concussion


subject: CHEBI:64312

object_name: Mild Traumatic Brain Injury


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Insulin resistance


subject: CHEBI:3181

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:53394043

object_name: pulmonary fibrosis


subject: PUBCHEM.COMPOUND:53394043

object_name: Pulmonary Fibrosis, CTCAE


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost


subject: PUBCHEM.COMPOUND:6435378


subject: CHEBI:16595

object_name: Overweight and obesity


subject: CHEBI:16595

object_name: Hypercholesterolemia


subject: CHEBI:16595


subject: CHEBI:16595

object_name: hypertension


subject: CHEBI:16595

object_name: Hypertension, CTCAE


subject: CHEBI:16783


subject: CHEBI:16783


subject: CHEBI:16783


subject: CHEBI:16783


subject: CHEBI:16783


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: UNII:73B0K5S26A

object_name: granulomatosis with polyangiitis


subject: UMLS:C2348498

object_name: Refractory acute myeloid leukemia


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C4287724

object_name: Noninfectious panuveitis


subject: UMLS:C4287724

object_name: non-infectious posterior uveitis


subject: PUBCHEM.COMPOUND:10752953

object_name: healthy, no evidence of disease


subject: CHEBI:50182

subject_name: ARUNDINE


subject: UMLS:C3695947

subject_name: Cannabis sativa subsp. flowering top extract

object_name: Cannabis intoxication


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: Prostate cancer recurrent


subject: CHEBI:17347

subject_name: Testosterone


subject: UNII:XDE2GOF1JT

subject_name: LUVELTAMAB TAZEVIBULIN

object_name: ovarian carcinoma


subject: UNII:XDE2GOF1JT

object_name: malignant epithelial tumor of ovary


subject: UNII:XDE2GOF1JT

object_name: ovarian cancer


subject: UNII:XDE2GOF1JT

object_name: ovarian neoplasm


subject: UNII:XDE2GOF1JT

object_name: primary peritoneal carcinoma


subject: UNII:XDE2GOF1JT

object_name: Primary Peritoneal Cancer


subject: UNII:XDE2GOF1JT

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:XDE2GOF1JT

object_name: fallopian tube carcinoma


subject: UNII:XDE2GOF1JT

object_name: fallopian tube cancer


subject: UMLS:C4764024

subject_name: Anti-FolRa ADC STRO-002


subject: UMLS:C4764024


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821

object_name: High Risk Neuroblastoma


subject: UMLS:C2984517

object_name: Disseminated neuroblastoma


subject: UMLS:C2984517

object_name: Metastatic Neuroblastoma


subject: UMLS:C2984517

object_name: Stage 4S neuroblastoma


subject: PUBCHEM.COMPOUND:72809956

subject_name: QS 21


subject: PUBCHEM.COMPOUND:72809956

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:72809956

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:72809956


subject: PUBCHEM.COMPOUND:72809956


subject: PUBCHEM.COMPOUND:72809956


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:38940

object_name: Adult Mixed Glioma


subject: CHEBI:38940

object_name: Adult Gliosarcoma


subject: CHEBI:38940

object_name: adult oligodendroglioma


subject: CHEBI:38940

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:38940

object_name: Adult Pineal Gland Astrocytoma


subject: CHEBI:38940

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Primary Sjögren's syndrome


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C2699335


subject: CHEBI:18248

subject_name: Iron

object_name: congenital heart disease


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: diffuse large B-cell lymphoma


subject: UNII:OS7097575K

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:OS7097575K

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C2700161

object_name: prostate carcinoma


subject: UMLS:C2700161

object_name: prostate cancer


subject: CHEBI:18258

subject_name: Liothyronine


subject: CHEBI:18258


subject: UMLS:C0010826

subject_name: Cytomel


subject: UMLS:C0010826


subject: UMLS:C1964321

subject_name: CHLORELLA (pharmacologic substance)

object_name: type 2 diabetes mellitus


subject: UMLS:C1964321

object_name: Diabetes


subject: UMLS:C1964321

object_name: diabetes mellitus


subject: CHEBI:5856

subject_name: Ibutilide

object_name: atrial fibrillation


subject: CHEBI:5856

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:5856

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:2723854

subject_name: Indigo carmine

object_name: inflammatory bowel disease


subject: UNII:1G5BK41P4F

subject_name: Indigo


subject: CHEBI:90117

subject_name: indigo carmine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Ischemic maculopathy


subject: UNII:2J9QE0TM5I

object_name: Childhood Solid Neoplasm


subject: UNII:2J9QE0TM5I

object_name: Adult Solid Neoplasm


subject: UNII:2J9QE0TM5I

object_name: Solid Neoplasm


subject: UNII:2J9QE0TM5I

object_name: colorectal cancer


subject: UNII:2J9QE0TM5I

object_name: colorectal carcinoma


subject: UNII:2J9QE0TM5I

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2974542

subject_name: CKD 516


subject: UMLS:C2974542


subject: UMLS:C2974542


subject: UMLS:C2974542


subject: UMLS:C2974542


subject: UMLS:C2974542


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: Breastfeeding (mother)


subject: UNII:QX45B99R3J

object_name: pregnancy related


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: aortic valve disease 2


subject: CHEBI:68579

object_name: aortic valve disease 3


subject: CHEBI:68579

object_name: Stenosis of aorta


subject: CHEBI:68579

object_name: Ventricular Outflow Obstruction


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: post term pregnancy


subject: UMLS:C5203530

object_name: Abnormal vaginal bleeding


subject: UMLS:C5203530

object_name: Vaginal Hemorrhage


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: endometrial carcinoma


subject: UNII:4B93MGE4AL

object_name: Disseminated Malignant Neoplasm


subject: UNII:4B93MGE4AL

object_name: Embolism, Tumor


subject: UNII:4B93MGE4AL

object_name: Neoplasm Metastasis


subject: UNII:4B93MGE4AL

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: functional gastric disease


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:231683

subject_name: Anakinra

object_name: indolent plasma cell myeloma


subject: CHEBI:231683

object_name: smoldering plasma cell myeloma


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: UMLS:C1568660

object_name: Advanced breast cancer


subject: CHEBI:16069

subject_name: Imidazole

object_name: adrenal cortex carcinoma


subject: CHEBI:16069

object_name: adenoid cystic carcinoma


subject: CHEBI:16069

object_name: salivary gland adenoid cystic carcinoma


subject: CHEBI:39168

subject_name: Imidacloprid


subject: CHEBI:39168


subject: CHEBI:39168


subject: UMLS:C0796561

subject_name: Melanoma vaccine

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C0796561

object_name: Metastatic Cutaneous Melanoma


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: Disorders associated with peritoneal dialysis


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UMLS:C1134640

subject_name: Recombinant Fowlpox-Prostate Specific Antigen Vaccine

object_name: prostate cancer


subject: UMLS:C1134640

object_name: prostate neoplasm


subject: UMLS:C0218633

subject_name: molgramostim


subject: UMLS:C0218633


subject: UMLS:C1514794

subject_name: Recombinant Vaccinia-Prostate Specific Antigen


subject: UMLS:C1514794


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: hypertension


subject: CHEBI:3614

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:10752953

object_name: papilloma


subject: CHEBI:50182

subject_name: ARUNDINE


subject: UMLS:C0114346

subject_name: Dimesna


subject: CHEBI:38940

subject_name: Sunitinib

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:38940

object_name: childhood central nervous system mixed germ cell tumor


subject: CHEBI:38940

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:38940

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: CHEBI:38940

object_name: Childhood Central Nervous System Embryonal Neoplasm


subject: CHEBI:38940

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: CHEBI:38940

object_name: central nervous system endodermal sinus tumor


subject: CHEBI:38940

object_name: pediatric CNS choriocarcinoma


subject: CHEBI:38940

object_name: childhood central nervous system germinoma


subject: CHEBI:38940

object_name: Childhood Central Nervous System Teratoma


subject: CHEBI:38940

object_name: CNS metastases


subject: CHEMBL.COMPOUND:CHEMBL2108632

subject_name: PLATELETS

object_name: Bleeding ulcer


subject: UMLS:C0443116

subject_name: Platelets Product


subject: CHEBI:10082

subject_name: Xylometazoline

object_name: common cold


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Chronic Myelomonocytic Leukemia-0


subject: CHEBI:2038

subject_name: Azacitidine


subject: UNII:TYH386V3WJ

subject_name: Seclidemstat

object_name: Chronic Myelomonocytic Leukemia-2


subject: UNII:TYH386V3WJ

object_name: Myelodysplasia


subject: UNII:TYH386V3WJ

object_name: Adult Myelodysplastic Syndrome


subject: UNII:TYH386V3WJ

object_name: childhood myelodysplastic syndrome


subject: UNII:TYH386V3WJ

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:TYH386V3WJ


subject: UNII:TYH386V3WJ

object_name: Chronic Myelomonocytic Leukemia-1


subject: UNII:TYH386V3WJ

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: UNII:TYH386V3WJ

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:TYH386V3WJ

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:75551

object_name: plasma cell myeloma


subject: CHEBI:90942

subject_name: Ixazomib

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:141441

subject_name: Ile-Thr


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Unresectable Solid Neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881

object_name: BRAF V600 Protein Variation


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:63637


subject: CHEBI:63637

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:63637

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:63637


subject: CHEBI:6970

subject_name: Mometasone

object_name: obstructive sleep apnea syndrome


subject: CHEBI:6970

object_name: Bedwetting


subject: CHEBI:6970

object_name: enuresis


subject: CHEBI:6970

object_name: Urinary incontinence of non-organic origin


subject: CHEBI:6970

object_name: Urinary incontinence


subject: CHEBI:6970

object_name: sleep apnea


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: urinary system disorder


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:114785

subject_name: Erlotinib

object_name: neoplastic meningitis


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: UMLS:C1709429


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Allergic Fungal Rhinosinusitis


subject: UMLS:C3658854


subject: MESH:C000627745

object_name: Constipation


subject: MESH:C000627745

object_name: Constipation, CTCAE


subject: UMLS:C5139953

object_name: type 2 diabetes mellitus


subject: UMLS:C5139821

subject_name: Efinopegdutide


subject: CHEBI:17460

subject_name: Thioctamide

object_name: Androgen excess


subject: UNII:5L84K4IEN9

object_name: schizophrenia


subject: UNII:ZLW14X2D30

object_name: plasma cell myeloma


subject: UMLS:C0108779

subject_name: CD3 Antigens


subject: CHEBI:140628

subject_name: Secnidazole

object_name: trichomoniasis


subject: CHEBI:240107

subject_name: Bromfenac

object_name: age-related macular degeneration


subject: UMLS:C5706312

object_name: lung adenocarcinoma


subject: UMLS:C5706312

object_name: non-small cell lung carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: adult dermatomyositis


subject: CHEBI:63791

object_name: dermatomyositis


subject: CHEBI:5775

subject_name: Hydralazine

object_name: hypertension, pregnancy-induced


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Recurrent disease


subject: CHEBI:76016

object_name: Global Relapse in Viscera


subject: CHEBI:76016

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:76016

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:76016

object_name: Global Relapse


subject: CHEBI:76016

object_name: Global Relapse in Skin


subject: CHEBI:76016

object_name: Global Relapse in Blood


subject: CHEBI:76016

object_name: Cognitive impairment


subject: CHEBI:149504

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:149504

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:149504

object_name: morbid obesity


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: familial medullary thyroid carcinoma


subject: UNII:GKF8S4C432

object_name: medullary thyroid gland carcinoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: opiate dependence


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: metastatic colorectal cancer


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: CHEBI:138655

object_name: head and neck neoplasm


subject: CHEBI:138655

object_name: head and neck cancer


subject: PR:000015485

subject_name: spermatogenesis-associated protein 2


subject: PR:000015485


subject: PR:000001919


subject: PR:000001919


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1


subject: PR:000001543


subject: UMLS:C5392069

subject_name: CTLA-4 Inhibitors


subject: UMLS:C5392069


subject: CHEBI:125427

object_name: Stage 1 chronic kidney disease


subject: CHEBI:125427

object_name: Stage 2 chronic kidney disease


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0063891

subject_name: Iscador


subject: UMLS:C0083104

subject_name: juzentaihoto

object_name: cancer-related condition


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:28939

object_name: aplastic anemia


subject: CHEBI:28939

object_name: idiopathic aplastic anemia


subject: UMLS:C4079901

object_name: anemia


subject: UMLS:C4079901

object_name: Anemia, CTCAE


subject: UMLS:C4079901

object_name: Chronic uremia


subject: CHEBI:94781

object_name: endogenous depression


subject: CHEBI:94781

object_name: major depressive disorder


subject: CHEBI:3611

subject_name: Chlordiazepoxide


subject: CHEBI:3611


subject: DRUGBANK:DB14277

subject_name: Tripterygium wilfordii whole


subject: CHEBI:7025

subject_name: Mupirocin

object_name: HIV infection


subject: CHEBI:5693

subject_name: Hexachlorophene


subject: CHEBI:5693

object_name: staphylococcal infection


subject: UMLS:C0308205

subject_name: Phisohex


subject: UMLS:C0308205


subject: CHEBI:164200

subject_name: Triclosan


subject: CHEBI:164200


subject: CHEBI:32682

subject_name: L-argininium

object_name: cardiovascular disorder


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:50730

subject_name: Montelukast

object_name: Infusion reaction


subject: CHEBI:29548

subject_name: Streptomyces coelicolor calcium-dependent antibiotic CDA4b

object_name: leukemia


subject: CHEBI:29548

object_name: childhood leukemia


subject: UMLS:C3641169

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: type 1 diabetes mellitus


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product